Literature DB >> 24907862

[Quaternary prevention: containment as an ethical necessity].

C Martínez González1, I Riaño Galán2, M Sánchez Jacob3, J González de Dios4.   

Abstract

The growing capacity of medicine to generate more iatrogenic events than ever, and the risk of unsustainability of health systems have led to new prevention concept: quaternary prevention aimed at restraining medicalization. Quaternary prevention is essential in the phenomenon called disease mongering, which could be translated as commercialization of disease. Encouraging this sort of prevention and halting the consequences of disease mongering requires the development of all the institutional potential for prevention, as well as all the personal willingness for restraint; it involves separating us from the unnecessary auspices of industry, being critical of our work, not being maleficent, respecting the principle of justice as managers of the limited public resources and making ourselves feel responsible for the social cost resulting from medical decisions. From this point of view, this work analyses neonatal screening, developments in the area of neonatology and primary health care.
Copyright © 2014 Asociación Española de Pediatría. Published by Elsevier Espana. All rights reserved.

Keywords:  Atención primaria; Bioethics; Bioética; Cribado neonatal; Disease mongering; Ethics; Neonatal screening; Neonatology; Neonatología; Pediatrics; Pediatría; Prevención cuaternaria; Primary care; Quaternary prevention; Ética

Mesh:

Year:  2014        PMID: 24907862     DOI: 10.1016/j.anpedi.2014.04.029

Source DB:  PubMed          Journal:  An Pediatr (Barc)        ISSN: 1695-4033            Impact factor:   1.500


  2 in total

1.  Quaternary prevention: need of the hour.

Authors:  Harshal T Pandve
Journal:  J Family Med Prim Care       Date:  2014 Oct-Dec

2.  [Impact of overdiagnosis and overtreatment on the patient, the health system and society].

Authors:  Txema Coll-Benejam; Rafael Bravo-Toledo; María Pilar Marcos-Calvo; María Pilar Astier-Peña
Journal:  Aten Primaria       Date:  2018-11       Impact factor: 1.137

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.